Premium
LHRH Analogues as Primary Treatment for Urinary Retention in Patients with Prostatic Carcinoma
Author(s) -
HAMPSON S. J.,
DAVIES J. H.,
CHARG C. R.,
SHEARER R. J.
Publication year - 1993
Publication title -
british journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 0007-1331
DOI - 10.1111/j.1464-410x.1993.tb16029.x
Subject(s) - urinary retention , urology , medicine , carcinoma , primary (astronomy) , prostatic diseases , prostate , oncology , cancer , physics , astronomy
Summary— Thirty‐one patients with retention of urine and carcinoma of the prostate were treated with LHRH analogues as primary therapy rather than prostatectomy; 21 patients voided without the need for surgical intervention. Patients presenting in acute retention of urine voided more readily than those presenting in chronic retention, with only 20% requiring surgery. This approach to treatment is safe, efficacious and cost effective.